For Quick Alerts
For Daily Alerts
Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated June 28, 2013 titled "Aurobindo Pharma receives Tentative Approval for Efavirenz+Lamivudine+ Tenofovir Disoproxil Fumarate Tablets, 600mg/300mg/300mg (NDA)".
For investment related articles, business news and mutual fund advise
You have already subscribed